Post-earnings recap
Reported
Fri, Aug 7, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
13%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Scholar Rock's earnings report shows a significant loss per share, which was below expectations. Despite this, the stock rose by 2.25%, likely due to investor optimism about the company's ongoing clinical programs. The lack of revenue data and guidance may leave some investors cautious moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | -$0.65 | N/A | -21.95% |
| Revenue | N/A | N/A | N/A |
Management acknowledged the challenges faced in the quarter. They emphasized their commitment to progressing their clinical pipeline.
Management did not provide specific revenue guidance for the upcoming quarters.
The focus remains on advancing their clinical programs despite the financial loss.